A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Mayo Clinic
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
Jonsson Comprehensive Cancer Center
M.D. Anderson Cancer Center
Massachusetts General Hospital
Northwestern University
Fred Hutchinson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins